Neola Medical (Sweden) Market Value
| NEOLA Stock | 2.20 0.08 3.51% |
| Symbol | Neola |
Neola Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Neola Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Neola Medical.
| 02/09/2023 |
| 11/30/2024 |
If you would invest 0.00 in Neola Medical on February 9, 2023 and sell it all today you would earn a total of 0.00 from holding Neola Medical AB or generate 0.0% return on investment in Neola Medical over 660 days. Neola Medical is related to or competes with Xvivo Perfusion, BICO Group, Bactiguard Holding, Stille AB, and SpectraCure. More
Neola Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Neola Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Neola Medical AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 26.58 | |||
| Value At Risk | (6.56) | |||
| Potential Upside | 6.62 |
Neola Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Neola Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Neola Medical's standard deviation. In reality, there are many statistical measures that can use Neola Medical historical prices to predict the future Neola Medical's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.47) | |||
| Total Risk Alpha | (1.14) | |||
| Treynor Ratio | (0.82) |
Neola Medical AB Backtested Returns
Neola Medical AB has Sharpe Ratio of -0.0943, which conveys that the firm had a -0.0943% return per unit of risk over the last 3 months. Neola Medical exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Neola Medical's Risk Adjusted Performance of (0.06), mean deviation of 3.09, and Standard Deviation of 4.43 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.49, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Neola Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Neola Medical is expected to be smaller as well. At this point, Neola Medical AB has a negative expected return of -0.42%. Please make sure to verify Neola Medical's kurtosis, and the relationship between the value at risk and rate of daily change , to decide if Neola Medical AB performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.68 |
Very good reverse predictability
Neola Medical AB has very good reverse predictability. Overlapping area represents the amount of predictability between Neola Medical time series from 9th of February 2023 to 5th of January 2024 and 5th of January 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Neola Medical AB price movement. The serial correlation of -0.68 indicates that around 68.0% of current Neola Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.68 | |
| Spearman Rank Test | -0.49 | |
| Residual Average | 0.0 | |
| Price Variance | 0.18 |
Neola Medical AB lagged returns against current returns
Autocorrelation, which is Neola Medical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Neola Medical's stock expected returns. We can calculate the autocorrelation of Neola Medical returns to help us make a trade decision. For example, suppose you find that Neola Medical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Neola Medical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Neola Medical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Neola Medical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Neola Medical stock over time.
Current vs Lagged Prices |
| Timeline |
Neola Medical Lagged Returns
When evaluating Neola Medical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Neola Medical stock have on its future price. Neola Medical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Neola Medical autocorrelation shows the relationship between Neola Medical stock current value and its past values and can show if there is a momentum factor associated with investing in Neola Medical AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Neola Stock Analysis
When running Neola Medical's price analysis, check to measure Neola Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neola Medical is operating at the current time. Most of Neola Medical's value examination focuses on studying past and present price action to predict the probability of Neola Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neola Medical's price. Additionally, you may evaluate how the addition of Neola Medical to your portfolios can decrease your overall portfolio volatility.